EyePromise is a company that focuses on providing nutraceuticals, technology, and support to enhance and protect vision. Founded in 2001, the company's slogan "Upgrade Your Eyes" aligns with its mission to cater to individuals dependent on sight to perform at a higher level and those facing degenerative eye conditions. With a specialized focus on eye health and nutrition science, EyePromise offers a wide range of ocular nutraceuticals, including products for macular health, occasional dry eye, blood vessel integrity, and athletic visual performance.
In addition to its nutraceuticals, EyePromise also offers the QuantifEye MPS II, an industry-standard macular pigment optical density measurement instrument. This technology aids in accurately assessing eye health. Furthermore, the company provides comprehensive support partnerships with online and in-store support, aiming to deliver unmatched products and services. EyePromise received a $3.00M Venture Round investment on 01 October 2014. The investment came from DSM Venturing, highlighting the industry's recognition of the company's potential in enhancing eye care and vision protection.
EyePromise's dedication to improving vision and eye care presents a promising opportunity for investors aiming to support advancements in the healthcare and manufacturing industries. With a proven track record and specialized expertise, EyePromise stands out as a valuable player in the market, providing innovative solutions for individuals seeking to maintain and enhance their vision.